Navigation Links
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
Date:8/25/2013

ion in the U.S. with exclusivity until July 2019, and patents in the U.S. which extend until at least 2025.  Amgen believes there is a significant opportunity to grow Kyprolis, including potential expansion into earlier lines of multiple myeloma treatment and into international markets. 

Ongoing studies to support and extend Kyprolis' position in multiple myeloma include:

  • The ASPIRE trial, which is investigating the addition of Kyprolis to Revlimid® (lenalidomide)1 and dexamethasone in patients with relapsed multiple myeloma who have received one to three prior therapies. An interim analysis is expected to read out in 2014. ASPIRE is the confirmatory trial for full U.S. approval as well as a registration-enabling study for relapsed multiple myeloma in the U.S. and EU.
  • The FOCUS trial, which could support the EU filing for the indication of relapsed/refractory multiple myeloma, is also expected to read out in 2014.
  • The ENDEAVOR trial, underway to compare Kyprolis to Velcade® (bortezomib)2 in patients with relapsed multiple myeloma who have received one to three prior therapies.
  • The CLARION trial, underway to compare Kyprolis to Velcade in patients with newly diagnosed multiple myeloma.
  • Oprozomib, an investigational oral proteasome inhibitor, is in Phase 1b/2 trials and has the potential to play an important future role in the management of multiple myeloma.
  • Across the multiple myeloma platform, Amgen's experience in oncology can help guide Onyx's pipeline to successful approval and reimbursement.
  • Provides Additional Sources of Revenue Growth and Profitability

  • Nexavar® (sorafenib) tablets is Onyx and Bayer's oral kinase inhibitor, currently approved in the U.S. for unresectable hepatocellular carcinoma (HCC) and advanced renal cell carcinoma (RCC). It is being studied in lo
    '/>"/>

  • SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related medicine technology :

    1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
    2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
    3. Amgen to Present at the Baird Growth Stock Conference
    4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
    5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
    7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
    8. Amgen Completes Acquisition of KAI Pharmaceuticals
    9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
    10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
    11. Amgen To Present At The Baird Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
    (Date:7/1/2015)... -- Unilife Corporation (NASDAQ: UNIS and ASX: UNS), ... systems, announced today that its debt agreement with OrbiMed ... amendment removed a covenant that required Unilife to generate ... during the six months ended June 30, 2015. There ... of the debt agreement as part of this amendment. ...
    (Date:7/1/2015)... -- Qiming Venture Partners, today announces the promotion of ... William has been with Qiming for nearly ... Qiming healthcare deals, and assisted many of these companies ... success in healthcare is not a small part from ... outstanding advocacy and service mentality on behalf of all ...
    Breaking Medicine Technology:Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Qiming Announces the Promotion of William Hu to Managing Partner 2
    ... The U.S. Food and Drug Administration is warning consumers again ... King International and sold by various companies, due to serious ... Shoulder Flex Massager is a personal massage device sold ... intended to provide users with a deep tissue massage to ...
    ... Pharmaceuticals, Inc. (Nasdaq: AMPE)("Ampio" or the "Company"), a company ... drugs and new molecular entities ("NMEs"), announced today that ... to sell an aggregate approximately 2,220,255 of shares of ... "Shares"), at a price per share of $4.25 in ...
    Cached Medicine Technology:FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 2Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 3
    (Date:7/1/2015)... ... 01, 2015 , ... As if mood swings, cramps and child labor weren’t ... women: leg pain. Northeast Houston Vein Center is offering tips on the treatment options ... disease, is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, restless legs, ...
    (Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. is ... released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the Health ... available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is a ...
    (Date:7/1/2015)... ... 2015 , ... Boar’s Head Brand®, one of the nation’s ... Day celebrations with new takes on classic dishes. From chicken salad with a ... summertime get together. , “Celebrating with family, friends, and great food is an ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Author Francesca Camp wasn’t always a steadfast ... lap, so too did her support of the practice; a terrible car accident years ago ... new book, “Do I Need It ? (And What if I Do?): Answers to ...
    (Date:7/1/2015)... ... 2015 , ... Who doesn’t want a life filled with thriving positivity and ... between work and life, and positive friendships and relationships? , Dr. Marsha W. ... Wellbeing in Doctors. , With a focus on solving the epidemic of ill-being in ...
    Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2
    ... German Helmholtz Association announce the creation of two Franco-German joint ... foster the establishment of a new form of cooperation in ... The two research laboratories will be set up for an ... 250,000 Euros. The groups, cofinanced by the two institutions, will ...
    ... FRANKFURT. Salmonella is widely prevalent in the animal kingdom. The ... often is due to our body,s defence system, which manages ... healthy human being will only fall ill if he consumes ... such as eggs or meat. An international team of researchers, ...
    ... Friday, May 27 (HealthDay News) -- As grills around the country ... advice on how to ensure your barbeque or picnic is not ... Illness and a leading national advocate for food safety, urges people ... this summer: Keep a small cooler in the ...
    ... By Amanda Gardner HealthDay Reporter , THURSDAY, ... -- in more sedentary jobs, they,re packing on the pounds, ... obesity epidemic, new research suggests. Staring at the computer ... burning 120 to 140 fewer calories a day than they ...
    ... (May 26, 2011) Dr. Joseph P. Kerwin is a recipient ... his "influential contributions to space biomedical research and space medicine." Kerwin, ... the first U.S. medical doctor to travel in space when the ... a member of the first crew to live aboard the Skylab ...
    ... Reporter , THURSDAY, May 26 (HealthDay News) -- Precision-tinted glasses ... triggered by certain visual patterns, new research indicates. Up ... visual "aura," such as flashes of light, may benefit, says ... May 26 issue of the journal Cephalalgia . ...
    Cached Medicine News:Health News:The Helmholtz Association and Inserm create 2 joint research laboratories in France 2Health News:The Helmholtz Association and Inserm create 2 joint research laboratories in France 3Health News:Intestinal cell defense mechanism against bacteria 2Health News:Sedentary Jobs Helping to Drive Obesity Epidemic 2Health News:America's first doctor in space honored by Baylor College of Medicine 2Health News:Special Tinted Glasses May Stymie Migraines 2
    An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
    Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
    ... System - A Single Platform for ... with true load-and-go productivity and maximized ... and UF-100 for complete walkaway urinalysis. ... together deliver utmost reliability. Ease of ...
    ... is one of the 3 major naturally ... estrone). In terms of estrogenic activity, estriol ... Estriol is produced almost exclusively during pregnancy, ... the normal human fetus. During pregnancy, the ...
    Medicine Products: